S&P Futures
5,889.25 -3.25 (-0.06%) Dow Futures
43,039.00 -130.00 (-0.30%) Nasdaq Futures
20,516.00 -26.00 (-0.13%) Russell 2000 Futures
2,243.40 -2.80 (-0.12%) Crude Oil
71.11 -0.63 (-0.88%) Gold
2,769.40 +9.60 (+0.35%)
ALLO Nov 2024 2.500 call
| Previous Close | 0.5500 |
| Open | 0.5000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 2.50 |
| Expire Date | 2024-11-15 |
| Day's Range | 0.5000 - 0.5500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
GlobeNewswireArtiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
SAN DIEGO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and cancers, today announced the appointment of Alison Moore, Ph.D., as an independent member of its Board of Directors. Dr. Moore brings over 25 years of executive experience in the biotechnology and pharmaceutical industry, including an extensi
Insider MonkeyAllogene Therapeutics, Inc. (ALLO): Among the Rising Penny Stocks to Invest In Now
We recently compiled a list of the 7 Best Rising Penny Stocks To Invest In Now. In this article, we are going to take a look at where Allogene Therapeutics, Inc. (NASDAQ:ALLO) stands against the other rising penny stocks. Fed’s Rate Cut Sets the Stage for a Strong Q4 In an episode of Market Storylines on […]
